Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12808
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKerr, P Gen
dc.contributor.authorvan Bakel, Cen
dc.contributor.authorDawborn, J Ken
dc.date.accessioned2015-05-16T02:33:05Z
dc.date.available2015-05-16T02:33:05Z
dc.date.issued1989-05-16en
dc.identifier.citationNephron; 52(2): 166-9en
dc.identifier.govdoc2662042en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12808en
dc.description.abstractSymptoms were evaluated in 13 haemodialysis patients at dialysate temperatures between 37 and 35 degrees C. After a control period at 37 degrees C (stage 1) dialysate flow rate was increased from 300 ml/min in half the patients but no change in temperature was made (stage 2). In stage 3 dialysate temperature was reduced to 36.5 degrees C and in stage 4 to 35 degrees C. Blood pressure and temperature were measured pre- and post dialysis and patient completed a questionnaire indicating if they experienced any of nine specified symptoms: itch, restless legs, nausea, vomiting, headache, cramp, lethargy, hypotension and change in temperature. Trial stages were compared with chi 2 analysis using Yates correction. Symptoms per dialysis fell from 1.11 to 0.71 between stage 1 and 2 (p less than 0.0005). This was considered to be a trial effect. There was no further significant improvement in symptoms overall as the temperature was reduced to 35 degrees C. However, if complaints of coldness are excluded, there was a progressive reduction in symptoms from stage 1 to stage 4. Dialysate flow rate did not affect symptom reporting. There was no effect on body core temperature or blood pressure due to cool dialysate. Our results suggest there may be some benefit in lowering the dialysate temperature but this is small in relation to the placebo effect. Caution must be used in assessing similar studies using small numbers of dialyses.en
dc.language.isoenen
dc.subject.otherBlood Pressureen
dc.subject.otherBody Temperatureen
dc.subject.otherClinical Trials as Topicen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherPlacebosen
dc.subject.otherQuestionnairesen
dc.subject.otherRenal Dialysis.adverse effectsen
dc.subject.otherTemperatureen
dc.titleAssessment of the symptomatic benefit of cool dialysate.en
dc.typeJournal Articleen
dc.identifier.journaltitleNephronen
dc.identifier.affiliationRenal Unit, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages166-9en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/2662042en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.